STRASBOURG, May 27 — Even people with minor illness from the coronavirus can develop antibodies that could leave them immunised for several weeks or more, according to an early French study that tested hospital staff with mild infections. Researchers said…
Brian Kaminski, DO, ProMedica vice president of quality and patient safety, provides an update on the initial research of how different blood types are affected by COVID-19.
Subscribe to our channel! rupt.ly/subscribe Mandatory Credit: Oxford University First trials at the Oxford University raise hopes in the battle against the pandemic as results show that a coronavirus vaccine generated a “robust immune response” in the volunteers. Key researchers…
Here is the direct link to register your email for upcoming events, daily recipes, and other exclusive content. -*** ***YOU DO NOT NEED TO REGISTER IF YOU’VE ALREADY REGISTERED FOR PRIOR EVENTS!*** RSVP For The Pandemic Preparation Conference, October 17th,…
The COVID-19 vaccine being developed by researchers at the University of Oxford is considered one of the leading in the world, and researchers announced promising results of its first human trials. Charlie D’Agata reports on the vaccine that could provide…
Dr Alan Maryon-Davis of King’s College explains the promising preliminary results from AstraZeneca’s Covid-19 vaccine trials. #CoronavirusVaccine #AstraZeneca #OxfordUniversity Subscribe: Livestream: Facebook: Twitter: Instagram: Visit our website:
